-
The Current State Of The Breast Cancer Treatment Space
Tuesday, May 23, 2017 - 7:59am | 703Read More...Puma Biotechnology Inc (NASDAQ: PBYI) popped 88 percent Monday on news that its neratinib candidate, an early-stage breast cancer treatment for human epidermal growth factor receptor-2 (HER2) positive mutations, was advancing in the U.S. Food and Drug Administration investigatory process. For...
